Archive for September, 2010
Although adults sometimes dismiss it as a childhood rite of passage, bullying in school is now recognized as a form of aggression that may have long-lasting psychological ramifications — for both victims and perpetrators. Most research on bullying has been done in Australia and Europe, where rates of frequent bullying range from 2% of youths […]
Sipuleucel-T (Provenge), a “vaccine” that uses a patients immune system to fight advanced stage disease, was approved by the FDA in April 2010. The vaccine does not prevent cancer; rather, it helps men with advanced stage, hormone-resistant disease live longer.
A prostate cancer diagnosis may send a man to the operating room or drive him to get radiation therapy—even when the cancer is unlikely to spread or cause harm. That’s causing some to wonder when a biopsy should really be done.
Research suggests that these drugs could potentially mask changes in a man’s PSA and interfere with the detection of prostate cancer.
This injectable form of hormone therapy received FDA approval in December 2008.
Researchers find that high-intensity focused ultrasound (HIFU) may be effective in treating localized recurrent prostate cancer while also minimizing the chances of side effects.
Prostate cancer drug treatments that block the activity of hormones have been associated with a higher risk of heart attack and heart disease. But a 2009 study suggests that these drugs may not cause cardiovascular problems after all.
Ever since the FDA approved the first cholesterol-lowering statin in 1987, use of the drugs has steadily increased, with an estimated 13 million Americans taking them to ward off heart and vascular disease. Recently, statins have gained additional attention, thanks to studies showing the drugs might have anticancer properties. But researchers have inconsistent answers to […]